Frédérique Chaperon

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

M. Arnone, Jeanne Maruani, Frédérique Chaperon et al. · Psychopharmacology · 1997 · 594 citations

Cannabis Use, Psychoactive Drug, Health Sciences +12

Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

Rainer Rupprecht, Gerhard Rammes, Daniela Eser et al. · Science · 2009 · 319 citations

Drug Target, Biochemistry, Translocator Protein +14

Involvement of central cannabinoid (CB 1 ) receptors in the establishment of place conditioning in rats

Frédérique Chaperon, Philippe Soubrié, Alain Puech et al. · Psychopharmacology · 1998 · 277 citations

Cannabis Use, Place Conditioning, Psychoactive Drug +14

Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines

John F. Cryan, Peter H. Kelly, Frédérique Chaperon et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 205 citations

The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Dominik Feuerbach, Kurt Lingenhoehl, Hans-Rudolf Olpe et al. · Neuropharmacology · 2008 · 127 citations

Synaptic Transmission, Neurotransmitter, Synaptic Signaling +16